Walleye Trading LLC Travere Therapeutics, Inc. Transaction History

Walleye Trading LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$15.3 - $22.61 $531,812 - $785,900	34,759 New	34,759 $533,000
Q4 2022 Feb 14, 2023	SELL	$18.47 - $26.14 $177,127 - $250,682	-9,590 Reduced 30.11%	22,260 $468,000
Q3 2022 Nov 14, 2022	BUY	$22.91 - $28.63 $729,683 - $911,865	31,850 New	31,850 $785,000
Q1 2022 May 16, 2022	SELL	$23.61 - $30.6 $73,521 - $95,288	-3,114 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$24.34 - $31.17 $588,589 - $753,752	-24,182 Reduced 88.59%	3,114 $97,000
Q3 2021 Nov 15, 2021	BUY	$12.98 - $25.03 $354,302 - $683,218	27,296 New	27,296 $662,000
Q1 2021 May 17, 2021	SELL	$23.37 - $31.77 $51,203 - $69,608	-2,191 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$19.17 - $27.87 $42,001 - $61,063	2,191 New	2,191 $60,000

196

84.9M

776K

900K

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.3B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.